A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo

Overview of attention for article published in Cancer Cell, November 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news: 5 news outlets
blogs: 1 blog
twitter: 101 X users

patent: 5 patents
f1000: 1 research highlight platform

Citations

dimensions_citation: 380 Dimensions

Readers on

mendeley: 399 Mendeley

Summary News Blogs X Patents Research highlights Dimensions citations

So far, Dimensions has found 380 publications that cite this research output.

380

The most recent citing publications are shown below. View all 380 publications that cite this research output on Dimensions.

Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease.

Article in Journal of Medicinal Chemistry (April 2024)

Liposomal STAT3-Degrading PROTAC Prodrugs Promote Anti-Hepatocellular Carcinoma Immunity via Chemically Reprogramming Cancer Stem Cells

Article in Nano Letters (April 2024)

Macrophages: plastic participants in the diagnosis and treatment of head and neck squamous cell carcinoma

Article in Frontiers in Immunology (April 2024)